 | • レポートコード：MRC2012A4098 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃運動障害治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃運動障害治療薬の種類別市場規模（ベルセトラグ、イパモレリン、TD-8954、その他）、用途別市場規模（病院、クリニック、家庭用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Theravance, Inc.、Targacept, Inc.、Helsinn Healthcare S.A.、Concert Pharmaceuticals, Inc.、ChironWells GmbH、 ・地域別グローバル市場分析 2015年-2020年 ・胃運動障害治療薬の北米市場（アメリカ、カナダ、メキシコ） ・胃運動障害治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃運動障害治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃運動障害治療薬の南米市場（ブラジル、アルゼンチン） ・胃運動障害治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ベルセトラグ、イパモレリン、TD-8954、その他 ・用途別分析：病院、クリニック、家庭用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Gastric Motility Disorder Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gastric Motility Disorder Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastric Motility Disorder Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastric Motility Disorder Drug market has been segmented into
Velusetrag
Ipamorelin
TD-8954
Others
By Application, Gastric Motility Disorder Drug has been segmented into:
Hospital
Clinic
Home Use
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastric Motility Disorder Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastric Motility Disorder Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastric Motility Disorder Drug market.
The report offers in-depth assessment of the growth and other aspects of the Gastric Motility Disorder Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastric Motility Disorder Drug Market Share Analysis
Gastric Motility Disorder Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastric Motility Disorder Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastric Motility Disorder Drug sales, revenue and market share for each player covered in this report.
The major players covered in Gastric Motility Disorder Drug are:
Theravance, Inc.
Targacept, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
ChironWells GmbH
Among other players domestic and global, Gastric Motility Disorder Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastric Motility Disorder Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastric Motility Disorder Drug, with price, sales, revenue and global market share of Gastric Motility Disorder Drug in 2018 and 2019.
Chapter 3, the Gastric Motility Disorder Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastric Motility Disorder Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastric Motility Disorder Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastric Motility Disorder Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gastric Motility Disorder Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastric Motility Disorder Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Velusetrag
1.2.3 Ipamorelin
1.2.4 TD-8954
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastric Motility Disorder Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Use
1.4 Overview of Global Gastric Motility Disorder Drug Market
1.4.1 Global Gastric Motility Disorder Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Theravance, Inc.
2.1.1 Theravance, Inc. Details
2.1.2 Theravance, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Theravance, Inc. SWOT Analysis
2.1.4 Theravance, Inc. Product and Services
2.1.5 Theravance, Inc. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Targacept, Inc.
2.2.1 Targacept, Inc. Details
2.2.2 Targacept, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Targacept, Inc. SWOT Analysis
2.2.4 Targacept, Inc. Product and Services
2.2.5 Targacept, Inc. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Helsinn Healthcare S.A.
2.3.1 Helsinn Healthcare S.A. Details
2.3.2 Helsinn Healthcare S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Helsinn Healthcare S.A. SWOT Analysis
2.3.4 Helsinn Healthcare S.A. Product and Services
2.3.5 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Concert Pharmaceuticals, Inc.
2.4.1 Concert Pharmaceuticals, Inc. Details
2.4.2 Concert Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Concert Pharmaceuticals, Inc. SWOT Analysis
2.4.4 Concert Pharmaceuticals, Inc. Product and Services
2.4.5 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 ChironWells GmbH
2.5.1 ChironWells GmbH Details
2.5.2 ChironWells GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ChironWells GmbH SWOT Analysis
2.5.4 ChironWells GmbH Product and Services
2.5.5 ChironWells GmbH Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastric Motility Disorder Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastric Motility Disorder Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastric Motility Disorder Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Gastric Motility Disorder Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastric Motility Disorder Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Gastric Motility Disorder Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastric Motility Disorder Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
4.3 Europe Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
4.5 South America Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastric Motility Disorder Drug Sales, Revenue and Market Share by Country
5.1.1 North America Gastric Motility Disorder Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastric Motility Disorder Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
5.3 Canada Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastric Motility Disorder Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Gastric Motility Disorder Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastric Motility Disorder Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
6.3 UK Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
6.4 France Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
6.5 Russia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
6.6 Italy Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastric Motility Disorder Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastric Motility Disorder Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastric Motility Disorder Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
7.3 Japan Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
7.4 Korea Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
7.5 India Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
7.7 Australia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastric Motility Disorder Drug Sales, Revenue and Market Share by Country
8.1.1 South America Gastric Motility Disorder Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastric Motility Disorder Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastric Motility Disorder Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastric Motility Disorder Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastric Motility Disorder Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastric Motility Disorder Drug Sales and Market Share by Type (2015-2020)
10.2 Global Gastric Motility Disorder Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Gastric Motility Disorder Drug Price by Type (2015-2020)
11 Global Gastric Motility Disorder Drug Market Segment by Application
11.1 Global Gastric Motility Disorder Drug Sales Market Share by Application (2015-2020)
11.2 Global Gastric Motility Disorder Drug Revenue Market Share by Application (2015-2020)
11.3 Global Gastric Motility Disorder Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastric Motility Disorder Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastric Motility Disorder Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Gastric Motility Disorder Drug Market Forecast (2021-2025)
12.2.2 Europe Gastric Motility Disorder Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastric Motility Disorder Drug Market Forecast (2021-2025)
12.2.4 South America Gastric Motility Disorder Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastric Motility Disorder Drug Market Forecast (2021-2025)
12.3 Gastric Motility Disorder Drug Market Forecast by Type (2021-2025)
12.3.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Gastric Motility Disorder Drug Market Share Forecast by Type (2021-2025)
12.4 Gastric Motility Disorder Drug Market Forecast by Application (2021-2025)
12.4.1 Global Gastric Motility Disorder Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Gastric Motility Disorder Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastric Motility Disorder Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastric Motility Disorder Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Theravance, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Theravance, Inc. Gastric Motility Disorder Drug Major Business
Table 9. Theravance, Inc. Gastric Motility Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 10. Theravance, Inc. SWOT Analysis
Table 11. Theravance, Inc. Gastric Motility Disorder Drug Product and Services
Table 12. Theravance, Inc. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Targacept, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Targacept, Inc. Gastric Motility Disorder Drug Major Business
Table 15. Targacept, Inc. Gastric Motility Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 16. Targacept, Inc. SWOT Analysis
Table 17. Targacept, Inc. Gastric Motility Disorder Drug Product and Services
Table 18. Targacept, Inc. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Helsinn Healthcare S.A. Basic Information, Manufacturing Base and Competitors
Table 20. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Major Business
Table 21. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 22. Helsinn Healthcare S.A. SWOT Analysis
Table 23. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product and Services
Table 24. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Concert Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Major Business
Table 27. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 28. Concert Pharmaceuticals, Inc. SWOT Analysis
Table 29. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product and Services
Table 30. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. ChironWells GmbH Basic Information, Manufacturing Base and Competitors
Table 32. ChironWells GmbH Gastric Motility Disorder Drug Major Business
Table 33. ChironWells GmbH Gastric Motility Disorder Drug Total Revenue (USD Million) (2017-2018)
Table 34. ChironWells GmbH SWOT Analysis
Table 35. ChironWells GmbH Gastric Motility Disorder Drug Product and Services
Table 36. ChironWells GmbH Gastric Motility Disorder Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Gastric Motility Disorder Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Gastric Motility Disorder Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Gastric Motility Disorder Drug Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Gastric Motility Disorder Drug Sales Market Share by Regions (2015-2020)
Table 41. Global Gastric Motility Disorder Drug Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Gastric Motility Disorder Drug Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Gastric Motility Disorder Drug Sales Market Share by Countries (2015-2020)
Table 44. North America Gastric Motility Disorder Drug Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Gastric Motility Disorder Drug Revenue Market Share by Countries (2015-2020)
Table 46. Europe Gastric Motility Disorder Drug Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Gastric Motility Disorder Drug Sales Market Share by Countries (2015-2020)
Table 48. Europe Gastric Motility Disorder Drug Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Gastric Motility Disorder Drug Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Gastric Motility Disorder Drug Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Gastric Motility Disorder Drug Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Gastric Motility Disorder Drug Sales Market Share by Countries (2015-2020)
Table 54. South America Gastric Motility Disorder Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Gastric Motility Disorder Drug Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Gastric Motility Disorder Drug Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Gastric Motility Disorder Drug Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Gastric Motility Disorder Drug Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Gastric Motility Disorder Drug Revenue Market Share by Countries (2015-2020)
Table 60. Global Gastric Motility Disorder Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Global Gastric Motility Disorder Drug Sales Share by Type (2015-2020)
Table 62. Global Gastric Motility Disorder Drug Revenue by Type (2015-2020) (USD Million)
Table 63. Global Gastric Motility Disorder Drug Revenue Share by Type (2015-2020)
Table 64. Global Gastric Motility Disorder Drug Sales by Application (2015-2020) (K Pcs)
Table 65. Global Gastric Motility Disorder Drug Sales Share by Application (2015-2020)
Table 66. Global Gastric Motility Disorder Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Gastric Motility Disorder Drug Market Share Forecast by Regions (2021-2025)
Table 68. Global Gastric Motility Disorder Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Gastric Motility Disorder Drug Market Share Forecast by Type (2021-2025)
Table 70. Global Gastric Motility Disorder Drug Sales Forecast by Application (2021-2025)
Table 71. Global Gastric Motility Disorder Drug Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastric Motility Disorder Drug Picture
Figure 2. Global Sales Market Share of Gastric Motility Disorder Drug by Type in 2019
Figure 3. Velusetrag Picture
Figure 4. Ipamorelin Picture
Figure 5. TD-8954 Picture
Figure 6. Others Picture
Figure 7. Gastric Motility Disorder Drug Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Home Use Picture
Figure 11. Global Gastric Motility Disorder Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Gastric Motility Disorder Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Gastric Motility Disorder Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Gastric Motility Disorder Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Gastric Motility Disorder Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Gastric Motility Disorder Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Gastric Motility Disorder Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Gastric Motility Disorder Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Gastric Motility Disorder Drug Revenue Market Share by Regions in 2018
Figure 40. North America Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Gastric Motility Disorder Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Gastric Motility Disorder Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Gastric Motility Disorder Drug Sales Market Share by Countries in 2018
Figure 48. North America Gastric Motility Disorder Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Gastric Motility Disorder Drug Revenue Market Share by Countries in 2018
Figure 50. United States Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Gastric Motility Disorder Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Gastric Motility Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Gastric Motility Disorder Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Gastric Motility Disorder Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Gastric Motility Disorder Drug Revenue Market Share by Regions 2019
Figure 64. China Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Gastric Motility Disorder Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Gastric Motility Disorder Drug Sales Market Share by Countries in 2019
Figure 71. South America Gastric Motility Disorder Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Gastric Motility Disorder Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Gastric Motility Disorder Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Gastric Motility Disorder Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Gastric Motility Disorder Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Gastric Motility Disorder Drug Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Gastric Motility Disorder Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Gastric Motility Disorder Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Gastric Motility Disorder Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Gastric Motility Disorder Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
胃運動障害治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastric Motility Disorder Drug Market The global Gastric Motility Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Motility Disorder Drug Scope and Market Size …- 糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…
- 過食症治療薬の世界市場（～2026年） Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusuall…
- 糖尿病性神経障害治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Diabetic Neurological Disorder Therapeutic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…
- 胃抑制性ポリペプチド受容体の世界市場（～2026年） Market Analysis and Insights: Global Gastric Inhibitory Polypeptide Receptor Market The global Gastric Inhibitory Polypeptide Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Inhibitory Polypeptide Rece…